ReumaNL, the Dutch Arthritis Society is the main patient representative for rheumatic diseases in the Netherlands with an international impact. ReumaNL funds innovative research and acts as a connector between patients, research organizations and other stakeholders both in the public and private domain. Their strategy is based on the focus of solutions for patients and to develop the steps forward to improve their daily quality of life.